Advances in Genomic Data and Biomarkers: Revolutionizing NSCLC Diagnosis and Treatment.

ABSTRACT: Non-small cell lung cancer (NSCLC) is a significant public health concern with high mortality rates. Recent advancements in genomic data, bioinformatics tools, and the utilization of biomarkers have improved the possibilities for early diagnosis, effective treatment, and follow-up in NSCLC. Biomarkers play a crucial role in precision medicine by providing measurable indicators of disease characteristics, enabling tailored treatment strategies. The integration of big data and artificial intelligence (AI) further enhances the potential for personalized medicine through advanced biomarker analysis. However, challenges remain in the impact of new biomarkers on mortality and treatment efficacy due to limited evidence. Data analysis, interpretation, and the adoption of precision medicine approac

SUBMITTER: Restrepo JC 

PROVIDER: S-EPMC10340640 | biostudies-literature | 2023 Jul

REPOSITORIES: biostudies-literature